DOI:
10.1055/s-00000169
American Journal of Perinatology Reports
LinksClose Window
References
Hauschild A, Grob JJ, Demidov LV , et al.
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Lancet 2012;
380: 358-365
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.